SFX by Ex Libris Inc.

Title:	Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter
Source:	Nature Genetics [1061-4036] Leegwater, Peter A.J. yr:2001

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	van der Knaap, Marjo S. "Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter." Annals of neurology 51.2: 264-270.
description	2.	Groot, P C C. "Evolution of the human alpha-amylase multigene family through unequal, homologous, and inter- and intrachromosomal crossovers." Genomics (1990): 97-105.
description	3.	Pronk, Jan C C. "Vanishing white matter disease: a review with focus on its genetics." Mental retardation and developmental disabilities research reviews 12.2 (2006): 123-128.
description	4.	Fogli, A.. "The effect of genotype on the natural history of eIF2B-related leukodystrophies." Neurology 62.9: 1509-1517.
description	5.	Krishnamoorthy, T. "Tight binding of the phosphorylated alpha subunit of initiation factor 2 (eIF2alpha) to the regulatory subunits of guanine nucleotide exchange factor eIF2B is required for inhibition of translation initiation." Molecular and cellular biology 21.15 (2001): 5018-30.
description	6.	van der Knaap, Marjo S S. "Vanishing white matter disease." Lancet. Neurology 5.5 (2006): 413-423.
description	7.	Pronk, J C C. "No predictive value of GC phenotypes for HIV infection and progression to AIDS." Human genetics 181-2.
description	8.	Wilson, C J J. "Vanishing white matter disease in a child presenting with ataxia." Journal of paediatrics and child health 41.1-2 (2004): 65-7.
description	9.	Knaap, M. "A new leukoencephalopathy with vanishing white matter." Neurology 48.4 (1997): 845-855.
description	10.	Gual, P. "Positive and negative regulation of insulin signaling through IRS-1 phosphorylation." Biochimie 87.1 (2005): 99-109.
description	11.	Richardson, Jonathan P. "Mutations causing childhood ataxia with central nervous system hypomyelination reduce eukaryotic initiation factor 2B complex formation and activity." Molecular and cellular biology 24.6 (2004): 2352-2363.
description	12.	Reiss, L. "The contribution of novel brain imaging techniques to understanding the neurobiology of mental retardation and developmental disabilities." Mental retardation and developmental disabilities research reviews 11.4 (2005): 331-339.
description	13.	O'Brien, John T T. "Vascular cognitive impairment." The American journal of geriatric psychiatry 14.9 (2006): 724-33.
description	14.	Bertini, P. "Fatal infantile leukodystrophy: a severe variant of CACH/VWM syndrome, allelic to chromosome 3q27." Neurology 57.2 (2001): 265-70.
description	15.	Fogli, A. "Cree leukoencephalopathy and CACH/VWM disease are allelic at the EIF2B5 locus." Annals of neurology 52.4 (2002): 506-10.
description	16.	Kimball, SR. "Regulation of Guanine Nucleotide Exchange through Phosphorylation of Eukaryotic Initiation Factor eIF2 alpha . Role of the alpha - and delta -Subunits of eIF2 beta." The Journal of biological chemistry 273.21 (1998): 12841-12845.
description	17.	Pavitt, G.D. D. "eIF2 independently binds two distinct eIF2B subcomplexes that catalyze and regulate guanine-nucleotide exchange." Genes & development 12.4 (1998): 514-26.
description	18.	Williams, DD. "Characterization of the initiation factor eIF2B and its regulation in Drosophila melanogaster." The Journal of biological chemistry 276.6 (2001): 3733-42.
description	19.	Ohlenbusch, A. "Identification of ten novel mutations in patients with eIF2B-related disorders." Human mutation 25.4 (2005): 411-411.
description	20.	Fogli, A.. "Ovarian failure related to eukaryotic initiation factor 2B mutations." American journal of human genetics 72.6: 1544-1550.